Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group N.V.

16.30
+0.88005.71%
Post-market: 16.00-0.3000-1.84%17:05 EST
Volume:34.14K
Turnover:543.41K
Market Cap:1.14B
PE:7.48K
High:16.50
Open:15.69
Low:15.65
Close:15.42
52wk High:21.34
52wk Low:7.50
Shares:69.67M
Float Shares:67.07M
Volume Ratio:1.17
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0022
EPS(LYR):-0.1800
ROE:0.03%
ROA:5.76%
PB:4.29
PE(LYR):-90.56

Loading ...

Pharming Group Issues 2026 Revenue Guidance; Shares Up Pre-Bell

MT Newswires Live
·
Feb 03

Pharming Group Down Nearly 17%, on Pace for Largest Percent Decrease Since September 2023 -- Data Talk

Dow Jones
·
Feb 03

Pharming Group (PHAR) Receives a Buy from Oppenheimer

TIPRANKS
·
Feb 02

Pharming Receives Complete Response Letter From FDA for Pediatric Immune Disorder Drug

MT Newswires Live
·
Feb 02

Pharming Group (PHAR) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Jan 28

Pharming Group Nv : Jefferies Raises Target Price to $23.4 From $19.5

THOMSON REUTERS
·
Jan 09

Pharming Group Reports Upbeat Preliminary 2025 Revenue

MT Newswires Live
·
Jan 08

Stock Track | Pharming Group N.V. Soars 8.93% on Strong Q3 Results and Raised FY25 Guidance

Stock Track
·
Nov 13, 2025

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday

Benzinga_recent_news
·
Nov 13, 2025

H.C. Wainwright Remains a Buy on Pharming Group (PHAR)

TIPRANKS
·
Nov 07, 2025

Stock Track | Pharming Group Soars 20.11% on Stellar Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 06, 2025

Stock Track | Pharming Group Soars 16.77% Pre-Market on Strong Q3 Results, Raised Guidance

Stock Track
·
Nov 06, 2025

Pharming Group NV reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

GlobeNewswire
·
Nov 06, 2025

Pharming Group NV expected to post breakeven results a share - Earnings Preview

Reuters
·
Nov 04, 2025

Pharming to Cut 20% of Non-Commercial, Non-Medical Headcount; Shares Fall

MT Newswires Live
·
Oct 07, 2025

Pharming announces 20% net reduction in non-commercial, non-medical headcount

TIPRANKS
·
Oct 06, 2025

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday as Government Shutdown Impact Weighs on Investors

MT Newswires Live
·
Oct 01, 2025

Pharming Gets FDA Priority Review for Infection-Causing Genetic Disorder Drug For Children Aged 4-11

MT Newswires Live
·
Oct 01, 2025

European Equities Traded in the US as American Depositary Receipts Rising Friday

MT Newswires Live
·
Sep 27, 2025